Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CVS Health : Activist Investor Takes Stake in CVS

share with twitter share with LinkedIn share with facebook
share via e-mail
11/25/2019 | 04:12pm EST

By Corrie Driebusch

Activist investor Starboard Value LP has taken a stake in CVS Health Corp. and held talks with the drugstore-and-insurance giant's management, according to people familiar with the matter.

The stake appears to be relatively small and the people said the talks, held recently, are amicable. How much Starboard currently owns and what it has discussed with the company couldn't be learned. But Starboard is one of the top activist-investment firms and its presence in a stock usually causes a company to sit up and take notice.

CVS shares have been on a roller-coaster ride since the company acquired health insurer Aetna Inc. for nearly $70 billion almost a year ago. The deal married CVS's sprawling drugstore network and pharmacy-benefit manager with one of the nation's largest health insurers.

The stock fell sharply after the Woonsocket, R.I., company in February issued a downbeat earnings projection for the year due to challenges in its pharmacy-benefits and long-term-care businesses. The shares went on to rebound sharply as the company reported a string of unexpectedly strong financial results, and research analysts have taken a more favorable view.

--Sharon Terlep contributed to this article.

Write to Corrie Driebusch at corrie.driebusch@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH CORPORATION
02/14CVS HEALTH : RespireRx Pharmaceuticals CEO Issues Progress and Status Report
AQ
02/13CVS HEALTH : Aetna Medicaid Launches New Approach To Integrated Care Supporting ..
PR
02/13CVS Reaps Benefits of Aetna Deal -- WSJ
DJ
02/13CVS HEALTH : pharmacy business lifted by high prices
AQ
02/12CVS HEALTH : Business Highlights
AQ
02/12Health Care Up As Investors Hedge On Chances Of Coronavirus Cure -- Health Ca..
DJ
02/12CVS Swings to Profit, Forecasts 2020 Results in Line With Estimates -- Update
DJ
02/12GLOBAL MARKETS LIVE: Boeing gets 0 orders in January, Lyft won’t be profitabl..
02/12CVS HEALTH : Q4 2019 Earnings Presentation
PU
02/12CVS HEALTH : swings to 4Q profit, lays out leadership changes
AQ
More news
Financials (USD)
Sales 2020 263 B
EBIT 2020 15 728 M
Net income 2020 7 223 M
Debt 2020 55 418 M
Yield 2020 2,80%
P/E ratio 2020 12,8x
P/E ratio 2021 11,6x
EV / Sales2020 0,56x
EV / Sales2021 0,52x
Capitalization 92 850 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 83,23  $
Last Close Price 71,37  $
Spread / Highest target 35,9%
Spread / Average Target 16,6%
Spread / Lowest Target -0,52%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President